Kirill Dmitriev, Chief Executive Office, Russian Direct Investment Fund, which is playing a crucial part in the development of the Russian vaccine told NDTV that clinical trials of the Sputnik V vaccine will begin in India this month and they expect to manufacture 300 million doses along with India.